2013
DOI: 10.7314/apjcp.2013.14.2.645
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Value of Tissue Vascular Endothelial Growth Factor Expression in Bladder Cancer: a Meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 32 publications
1
16
0
Order By: Relevance
“…Furthermore, ALCAM loss/downregulation is associated with a more invasive phenotype and poorer outcome in BC [49]. Since the key-role of VEGFA in vimentin expression promoting EMT changes [50] and chemoresistance [51] in BC cells, VEGFA overexpression may be partially responsible for the acquisition of the EMT phenotype and drug resistance found in CPS-treated BC cells.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, ALCAM loss/downregulation is associated with a more invasive phenotype and poorer outcome in BC [49]. Since the key-role of VEGFA in vimentin expression promoting EMT changes [50] and chemoresistance [51] in BC cells, VEGFA overexpression may be partially responsible for the acquisition of the EMT phenotype and drug resistance found in CPS-treated BC cells.…”
Section: Discussionmentioning
confidence: 99%
“…Angiogenesis is a complex process, which plays a role in various types of cancer [7679]. TQ inhibits angiogenesis by suppressing the activation of one of the important motifs of angiogenesis.…”
Section: The Implications Of N Sativa In Cancer Therapymentioning
confidence: 99%
“…VEGF is a multifunctional cytokine that exerts a variety of effects on vascular endothelial cells that together promote the formation of new blood vessels, increases vascular endothelial permeability, stimulates the proliferation of endothelial cells and promote cancer cell progression (Dvorak, 2002;Mohammed et al, 2007;Niu et al, 2010;Akdeniz et al, 2013;Huang et al, 2013;Zhang et al, 2013). In particular, serum VEGF-A levels are elevated in patients with HNSCC compared to healthy controls (De Schutter et al, 2005;Hong et al, 2009;Liang et al, 2013).…”
Section: Serum Vascular Endothelial Growth Factor-a (Vegf-a) As a Biomentioning
confidence: 99%